Skip to main navigation

albireo_logo_nav.svg

  • About
    • Overview
    • Management Team
    • Board of Directors
    • Partnering
    • Contact
  • Programs
    • Pipeline
    • A4250
    • A3384
    • Elobixibat
    • Nonalcoholic Steatohepatitis (NASH)
  • Science
    • Bile Acids and IBAT Inhibition
    • Publications
  • Patients & Families
    • Progressive Familial Intrahepatic Cholestasis (PFIC)
    • Nonalcoholic Steatohepatitis (NASH)
    • Chronic (Idiopathic) Constipation
    • Bile Acid Malabsorption (BAM)
  • Media & Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • 2018 Annual Meeting
    • Corporate Governance
    • Stock Information
    • Financials & Filings
    • Analyst Coverage
    • Contact Us
  • Careers
    • Current Openings

Albireo Provides Second Quarter 2018 Business Update

Financials menu

  • Financials & Filings

Stock Information menu

  • Stock Information

governance menu

  • Corporate Governance

Albireo Provides Second Quarter 2018 Business Update

Aug 7, 2018 at 8:30 AM EDT

Listen to webcast

Shareholder Tools

  • Printed Materials

    Printed Materials

  • Email Alerts

    Email Alerts

  • Downloads

    Downloads

  • RSS

    RSS

  • Print

    Print

  • Share

    Share


    • Facebook
    • Google
    • LinkedIn
    • Twitter
    • RSS
 
albireo-white

© 2018 Albireo Pharma, Inc.

Contact |  Terms of Use  |  Privacy Policy      twitter